Condition: Non-Hodgkin's Lymphoma · Hematopoietic Stem Cell Mobilization · Sponsor: The Affiliated People's Hospital of Ningbo University
This study utilizes a prospective, multicenter, randomized two-arm design to evaluate the efficacy and safety of the etoposide, cytarabine, and pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) combination therapy (EAP regimen) in mobilizing hematopoietic stem cells in patients with non-Hodgkin's lymphoma (NHL). A total of 99 NHL patients will be enrolled as research subjects and will be randomly allocated in a 2:1 ratio to compare the EAP regimen versus disease-specific chemotherapy mobilization regimen. The primary endpoint is the proportion of patients achieving the ideal collection value after a single collection (CD34+ cells ≥5×10\^6/kg).
This description comes directly from the study's public registry record.
Peipei Ye · 86-13685832706 · 39612903@qq.com
Ying Lu · 86-13486090834 · 814871416@qq.com
Always discuss trial participation with your own doctor first.
| Dongyang People's Hospital | Dongyang, Zhejiang, China | Recruiting |
| The Affiliated Hangzhou First People's Hospital | Hangzhou, Zhejiang, China | Recruiting |
| The First Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
| Tongde Hospital of Zhejiang Province | Hangzhou, Zhejiang, China | Recruiting |
| Huzhou central hospital | Huzhou, Zhejiang, China | Recruiting |
| The First Hospital of Jiaxing | Jiaxing, Zhejiang, China | Recruiting |
| Jinhua Municipal Central Hospital | Jinhua, Zhejiang, China | Recruiting |
| Jinhua People's Hospital | Jinhua, Zhejiang, China | Recruiting |
| Lishui Central Hospital | Lishui, Zhejiang, China | Recruiting |
| Ningbo Medical Center Lihuili Hospital | Ningbo, Zhejiang, China | Recruiting |
| The Affiliated People's Hospital of Ningbo University | Ningbo, Zhejiang, China | Recruiting |
| Shaoxing People's Hospital | Shaoxing, Zhejiang, China | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06520163